| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| varlilumab | t-cell activation antigen cd27 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Cancer of Head and Neck[MeSHID:D006258] Colorectal Cancer[MeSHID:D015179] Renal Cell Carcinoma[MeSHID:D002292] Recurrence (disease attribute)[MeSHID:D012008] Malignant neoplasm of ovary[MeSHID:D010051] Glioblastoma[MeSHID:D005909] |
63.65 | phase 2 | unknown |
| click here to return to the previous page | ||||||||